In a filing, NewAmsterdam Pharma Company NV revealed its Chief Accounting Officer Kooij Louise Frederika unloaded Company’s shares for reported $0.71 million on Oct 01 ’24. In the deal valued at $15.72 per share,45,000 shares were sold. As a result of this transaction, Kooij Louise Frederika now holds 0 shares worth roughly $0.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Kooij Louise Frederika bought 45,000 shares, generating $778,050 in total proceeds.
Before that, Audet Juliette Berangere bought 1,104 shares. NewAmsterdam Pharma Company NV shares valued at $17,333 were divested by the Chief Business Officer at a price of $15.70 per share. As a result of the transaction, Audet Juliette Berangere now holds 1,104 shares, worth roughly $27335.04.
TD Cowen initiated its NewAmsterdam Pharma Company NV [NAMS] rating to a Buy in a research note published recently. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in mid March with a ‘”a Sector outperform”‘ rating. Guggenheim began covering NAMS with “Buy” recommendation on January 18, 2024. Piper Sandler started covering the stock on January 16, 2024. It rated NAMS as “an Overweight”.
Price Performance Review of NAMS
On Tuesday, NewAmsterdam Pharma Company NV [NASDAQ:NAMS] saw its stock jump 0.69% to $24.76. Over the last five days, the stock has gained 29.30%. NewAmsterdam Pharma Company NV shares have risen nearly 121.67% since the year began. Nevertheless, the stocks have risen 147.85% over the past one year. While a 52-week high of $26.35 was reached on 01/25/24, a 52-week low of $8.64 was recorded on 01/02/24. SMA at 50 days reached $18.01, while 200 days put it at $19.38.
Levels Of Support And Resistance For NAMS Stock
The 24-hour chart illustrates a support level at 24.46, which if violated will result in even more drops to 24.15. On the upside, there is a resistance level at 24.97. A further resistance level may holdings at 25.17. The Relative Strength Index (RSI) on the 14-day chart is 80.24, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 4.21, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 1.32%. Stochastics %K at 97.59% indicates the stock is a selling.
How much short interest is there in NewAmsterdam Pharma Company NV?
A steep rise in short interest was recorded in NewAmsterdam Pharma Company NV stocks on 2024-10-31, growing by 0.28 million shares to a total of 0.72 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 0.44 million shares. There was a rise of 38.31%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 30, 2023 when RBC Capital Mkts began covering the stock and recommended ‘”an Outperform”‘ rating along with a $25 price target.
